KATIE BILLINGSLEY: Open Payments
NPI 1568831428 · NEW LEXINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,337 in 90 payments from 24 companies in 2025. Trend: 2023 $1,519 · 2024 $1,531 · 2025 $1,337
Food & beverage: $1,337
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $411 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $154 |
| GlaxoSmithKline, LLC. | 4 | $81 |
| Lilly USA, LLC | 5 | $81 |
| Corcept Therapeutics | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Aimmune Therapeutics, Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $37 |
| PFIZER INC. | 2 | $37 |
Products named: VRAYLAR, CAPLYTA, QULIPTA, UBRELVY, SHINGRIX, MOUNJARO, Korlym, AIRSUPRA.
Industry payments across OH — which companies pay providers there.
